Complete Response After One Cycle of Atezolizumab Plus Bevacizumab in Advanced Hepatocellular Carcinoma: Two High-Risk Contexts, Child-Pugh Class B and Advanced Age. - Kimura M; Otoyama Y; Nishikawa K; Imamura J; Kimura K (Cureus, 2025)